Clinical Trial Update: Social Safety Learning in the Brain Oxytocin System [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating social safety learning in the brain oxytocin system. The study targets social anxiety disorder (social phobia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Washington | Conditions: Social Phobia | Phase 2 | Status: COMPLETED